Return Peptide Library

Ac-SDKP

DLevel 1 evidence

Ac-SDKP

Cardiovascular and Vasoactive Peptides

AI Interpretation of This Peptide Generate Report

Basic Information

Categories

Endogenous Anti-fibrotic Peptide

Overview

Endogenous tetrapeptide; cleaved from thymosin β4, exhibiting broad antifibrotic activity across the heart, kidney, lung, and liver.

Efficacy Rating

Anti-fibrotic, Thymosin Fragment, Cardioprotection

Evidence Level

D-Rank

Evidence Type

No data available

Confidence

No data available

China Regulatory Status

Cosmetic Ingredient Directory

No data available

Food/Supplements

No data available

Medicine

No data available

Similar Peptide Recommendations

ELABELA

ELABELA

DCardiovascular and Vasoactive Peptides

APJ receptor, cardiovascular, kidney

Adrenomedullin

Adrenomedullin

BCardiovascular and Vasoactive Peptides

endogenous, vasodilator, sepsis

Angiotensin II

Angiotensin II

ACardiovascular and Vasoactive Peptides

hormones, FDA-approved, cardiovascular

Angiotensin-(1-7)

Angiotensin-(1-7)

BCardiovascular and Vasoactive Peptides

Endogenous, Cardiovascular, RAAS

Disclaimer

The content on this platform is for educational and informational purposes only and does not constitute medical advice, formulation guidance, or a guarantee of regulatory compliance. All efficacy claims are labeled with their evidence level; please consult a professional before making any decisions.